Gabapentin
NDC Package 43602-467-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Gabapentin is used with other medications to prevent and control seizures. Marketed by Ascent Pharmaceuticals, Inc, this product is identified by NDC 43602-467 and is authorized under FDA application ANDA214957.

Identification & Billing

NDC Package Code
43602-467-30
Package Description
30 TABLET in 1 BOTTLE
Product Code
43602-467
11-Digit Billing Format
43602046730

Clinical Specifications

Proprietary Name
Gabapentin
Dosage Form
-
Usage Information
Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Regulatory & Marketing

Labeler Name
Ascent Pharmaceuticals, Inc
FDA Application #
ANDA214957
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-01-2021
End Marketing Date
10-02-2021
Listing Expiration
10-02-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (43602-467). Click a package code to view its specific billing and regulatory data.

43602-467-05
500 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43602-467-30 identifies a specific commercial package of 30 tablet in 1 bottle of Gabapentin, labeled by Ascent Pharmaceuticals, Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ascent Pharmaceuticals, Inc on October 01, 2021. The current certification is valid through October 02, 2021.

What are the primary indications for this medication?

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

How is this Ascent Pharmaceuticals, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43602046730. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
43602-467-30
11-Digit CMS (5-4-2)
43602-0467-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.